Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer.

Biomarkers in cancer Pub Date : 2019-12-30 eCollection Date: 2019-01-01 DOI:10.1177/1179299X19897255
Nadezda Lipunova, Anke Wesselius, Kar K Cheng, Frederik J van Schooten, Jean-Baptiste Cazier, Richard T Bryan, Maurice P Zeegers
{"title":"Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer.","authors":"Nadezda Lipunova,&nbsp;Anke Wesselius,&nbsp;Kar K Cheng,&nbsp;Frederik J van Schooten,&nbsp;Jean-Baptiste Cazier,&nbsp;Richard T Bryan,&nbsp;Maurice P Zeegers","doi":"10.1177/1179299X19897255","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Many germline associations have been reported for urinary bladder cancer (UBC) outcomes and prognostic characteristics. It is unclear whether there are overlapping genetic patterns for various prognostic endpoints. We aimed to review contemporary literature on genetic associations with UBC prognostic outcomes and to identify potential overlap in reported genes.</p><p><strong>Methods: </strong>EMBASE, MEDLINE, and PubMed databases were queried for relevant articles in English language without date restrictions. The initial search identified 1346 articles. After exclusions, 112 studies have been summarized. Cumulatively, 316 single-nucleotide polymorphisms (SNPs) were reported across prognostic outcomes (recurrence, progression, death) and characteristics (tumor stage, grade, size, age, risk group). There were considerable differences between studied outcomes in the context of genetic associations. The most commonly reported SNPs were located in <i>OGG1, TP53</i>, and <i>MDM2</i>. For outcomes with the highest number of reported associations (ie, recurrence and death), functional enrichment annotation yields different terms, potentially indicating separate biological mechanisms.</p><p><strong>Conclusions: </strong>Our study suggests that all UBC prognostic outcomes may have different biological origins with limited overlap. Further validation of these observations is essential to target a phenotype that could best predict patient outcome and advance current management practices.</p>","PeriodicalId":72377,"journal":{"name":"Biomarkers in cancer","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179299X19897255","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomarkers in cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1179299X19897255","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Introduction: Many germline associations have been reported for urinary bladder cancer (UBC) outcomes and prognostic characteristics. It is unclear whether there are overlapping genetic patterns for various prognostic endpoints. We aimed to review contemporary literature on genetic associations with UBC prognostic outcomes and to identify potential overlap in reported genes.

Methods: EMBASE, MEDLINE, and PubMed databases were queried for relevant articles in English language without date restrictions. The initial search identified 1346 articles. After exclusions, 112 studies have been summarized. Cumulatively, 316 single-nucleotide polymorphisms (SNPs) were reported across prognostic outcomes (recurrence, progression, death) and characteristics (tumor stage, grade, size, age, risk group). There were considerable differences between studied outcomes in the context of genetic associations. The most commonly reported SNPs were located in OGG1, TP53, and MDM2. For outcomes with the highest number of reported associations (ie, recurrence and death), functional enrichment annotation yields different terms, potentially indicating separate biological mechanisms.

Conclusions: Our study suggests that all UBC prognostic outcomes may have different biological origins with limited overlap. Further validation of these observations is essential to target a phenotype that could best predict patient outcome and advance current management practices.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
系统综述:癌症预后因素的遗传相关性。
引言:许多种系关联已被报道为膀胱癌症(UBC)的结果和预后特征。目前尚不清楚各种预后终点是否存在重叠的遗传模式。我们的目的是回顾当代有关遗传与UBC预后结果的文献,并确定已报道基因的潜在重叠。方法:在EMBASE、MEDLINE和PubMed数据库中查询相关英文文章,不受日期限制。最初的搜索发现了1346篇文章。排除后,总结了112项研究。根据预后结果(复发、进展、死亡)和特征(肿瘤分期、级别、大小、年龄、风险组),共报告了316个单核苷酸多态性(SNPs)。在基因关联的背景下,研究结果之间存在相当大的差异。最常见的SNPs位于OGG1、TP53和MDM2中。对于报告关联数最高的结果(即复发和死亡),功能富集注释产生不同的术语,可能表明不同的生物学机制。结论:我们的研究表明,所有UBC预后结果可能具有不同的生物学起源,重叠有限。对这些观察结果的进一步验证对于针对能够最好地预测患者结果和推进当前管理实践的表型至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer. Behavioural Response Alteration in Caenorhabditis elegans to Urine After Surgical Removal of Cancer: Nematode-NOSE (N-NOSE) for Postoperative Evaluation. Chemotherapy Resistance in Advanced Ovarian Cancer Patients. Multivariate Index Assay Is Superior to CA125 and HE4 Testing in Detection of Ovarian Malignancy in African-American Women. Following Chemotherapy: Serum Cytokine (Tumor Necrosis Factor, Interleukin-2, Interleukin-11), Immunoglobulin, Complement, Vascular Endothelial Growth Factor Levels, and the Systemic Symptoms like Capillary Leak Syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1